ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 152 filers reported holding ANI PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 9.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $315,556 | +12.5% | 5,435 | +4.3% | 0.00% | – |
Q2 2023 | $280,454 | +39.2% | 5,210 | +2.7% | 0.00% | – |
Q1 2023 | $201,420 | -1.3% | 5,071 | 0.0% | 0.00% | – |
Q4 2022 | $204,006 | -22.1% | 5,071 | -10.8% | 0.00% | – |
Q4 2021 | $262,000 | +17.0% | 5,682 | -10.9% | 0.00% | – |
Q2 2021 | $224,000 | -4.7% | 6,377 | -1.8% | 0.00% | – |
Q1 2021 | $235,000 | -3.7% | 6,497 | +8.3% | 0.00% | – |
Q1 2020 | $244,000 | -29.5% | 6,001 | +7.0% | 0.00% | – |
Q4 2019 | $346,000 | -18.2% | 5,608 | -4.1% | 0.00% | – |
Q3 2019 | $423,000 | -12.4% | 5,850 | -0.4% | 0.00% | -100.0% |
Q2 2019 | $483,000 | +121.6% | 5,872 | +90.4% | 0.00% | – |
Q1 2019 | $218,000 | -47.8% | 3,084 | -50.7% | 0.00% | – |
Q2 2018 | $418,000 | +15.8% | 6,255 | +1.0% | 0.00% | – |
Q1 2018 | $361,000 | -10.9% | 6,196 | -1.3% | 0.00% | – |
Q4 2017 | $405,000 | +20.9% | 6,280 | -1.5% | 0.00% | – |
Q3 2017 | $335,000 | +10.2% | 6,374 | -1.8% | 0.00% | – |
Q2 2017 | $304,000 | -5.3% | 6,493 | +0.2% | 0.00% | – |
Q1 2017 | $321,000 | -6.1% | 6,478 | +14.9% | 0.00% | – |
Q4 2016 | $342,000 | -8.6% | 5,640 | +0.1% | 0.00% | -100.0% |
Q3 2016 | $374,000 | +15.8% | 5,633 | -2.6% | 0.00% | – |
Q2 2016 | $323,000 | +80.4% | 5,782 | +4.3% | 0.00% | – |
Q1 2016 | $179,000 | -26.3% | 5,543 | +3.0% | 0.00% | – |
Q4 2015 | $243,000 | +14.6% | 5,384 | 0.0% | 0.00% | – |
Q3 2015 | $212,000 | -34.8% | 5,384 | +2.6% | 0.00% | – |
Q2 2015 | $325,000 | +9.1% | 5,246 | +9.9% | 0.00% | – |
Q1 2015 | $298,000 | +12.5% | 4,772 | +1.4% | 0.00% | – |
Q4 2014 | $265,000 | +120.8% | 4,704 | +10.3% | 0.00% | – |
Q3 2014 | $120,000 | -24.1% | 4,265 | -6.7% | 0.00% | – |
Q2 2014 | $158,000 | +5166.7% | 4,570 | +5093.2% | 0.00% | – |
Q1 2014 | $3,000 | -70.0% | 88 | -82.1% | 0.00% | – |
Q4 2013 | $10,000 | +900.0% | 492 | +392.0% | 0.00% | – |
Q3 2013 | $1,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |